Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Repros Approved for Trading on Nasdaq Capital Market
Repros Approved for Trading on Nasdaq Capital Market
Repros Approved for Trading on Nasdaq Capital Market
Submitted by
admin
on January 16, 2010 - 11:10am
Source:
Yahoo/BusinessWire
News Tags:
Repros Therapeutics
NASDAQ
Headline:
Repros Approved for Trading on Nasdaq Capital Market
Do Not Allow Advertisers to Use My Personal information
